BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 38732124)

  • 21. Kamikihito Ameliorates Lipopolysaccharide-Induced Sickness Behavior via Attenuating Neural Activation, but Not Inflammation, in the Hypothalamic Paraventricular Nucleus and Central Nucleus of the Amygdala in Mice.
    Araki R; Nishida S; Hiraki Y; Li F; Matsumoto K; Yabe T
    Biol Pharm Bull; 2016; 39(2):289-94. PubMed ID: 26830488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of TREK currents by the neuroprotective agent riluzole in mouse sympathetic neurons.
    Cadaveira-Mosquera A; Ribeiro SJ; Reboreda A; Pérez M; Lamas JA
    J Neurosci; 2011 Jan; 31(4):1375-85. PubMed ID: 21273422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Negative Influence by the Force: Mechanically Induced Hyperpolarization via K
    Lengyel M; Enyedi P; Czirják G
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium permeable and "hypersensitive" TREK-1 channels cause ventricular tachycardia.
    Decher N; Ortiz-Bonnin B; Friedrich C; Schewe M; Kiper AK; Rinné S; Seemann G; Peyronnet R; Zumhagen S; Bustos D; Kockskämper J; Kohl P; Just S; González W; Baukrowitz T; Stallmeyer B; Schulze-Bahr E
    EMBO Mol Med; 2017 Apr; 9(4):403-414. PubMed ID: 28242754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and pharmacological inhibition of two-pore domain potassium channel TREK-1 alters depression-related behaviors and neuronal plasticity in the hippocampus in mice.
    Wu F; Sun H; Gong W; Li X; Pan Z; Shan H; Zhang Z
    CNS Neurosci Ther; 2021 Feb; 27(2):220-232. PubMed ID: 32864894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Contribution of KCNQ and TREK Channels to the Resting Membrane Potential in Sympathetic Neurons at Physiological Temperature.
    Rivas-Ramírez P; Reboreda A; Rueda-Ruzafa L; Herrera-Pérez S; Lamas JA
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of TREK-1, but Not TREK-2, Channel by Mood Stabilizers.
    Kim EJ; Lee DK; Hong SG; Han J; Kang D
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. K
    Lolicato M; Arrigoni C; Mori T; Sekioka Y; Bryant C; Clark KA; Minor DL
    Nature; 2017 Jul; 547(7663):364-368. PubMed ID: 28693035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stretch-activated two-pore-domain (K
    Schmidt C; Wiedmann F; Kallenberger SM; Ratte A; Schulte JS; Scholz B; Müller FU; Voigt N; Zafeiriou MP; Ehrlich JR; Tochtermann U; Veres G; Ruhparwar A; Karck M; Katus HA; Thomas D
    Prog Biophys Mol Biol; 2017 Nov; 130(Pt B):233-243. PubMed ID: 28526353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequential phosphorylation mediates receptor- and kinase-induced inhibition of TREK-1 background potassium channels.
    Murbartián J; Lei Q; Sando JJ; Bayliss DA
    J Biol Chem; 2005 Aug; 280(34):30175-84. PubMed ID: 16006563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Two-pore potassium channel TREK-1 (K2P2.1) regulates NLRP3 inflammasome activity in macrophages.
    Immanuel CN; Teng B; Dong BE; Gordon EM; Luellen C; Lopez B; Harding J; Cormier SA; Fitzpatrick EA; Schwingshackl A; Waters CM
    Am J Physiol Lung Cell Mol Physiol; 2024 Mar; 326(3):L367-L376. PubMed ID: 38252657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of TREK-1 (
    Zyrianova T; Lopez B; Zou K; Gu C; Pham D; Talapaneni S; Waters CM; Olcese R; Schwingshackl A
    Am J Physiol Lung Cell Mol Physiol; 2023 Jan; 324(1):L64-L75. PubMed ID: 36410022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muscimol Directly Activates the TREK-2 Channel Expressed in GABAergic Neurons through Its N-Terminus.
    Kim EJ; Kwon OS; Hur CG; Nyiramana MM; Lee DK; Hong SG; Han J; Kang D
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanosensitive TREK-1 two-pore-domain potassium (K
    Wiedmann F; Rinné S; Donner B; Decher N; Katus HA; Schmidt C
    Prog Biophys Mol Biol; 2021 Jan; 159():126-135. PubMed ID: 32553901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
    Vivier D; Bennis K; Lesage F; Ducki S
    J Med Chem; 2016 Jun; 59(11):5149-57. PubMed ID: 26588045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of GABA
    Chang YT; Ling J; Gu JG
    Mol Pain; 2021; 17():17448069211042963. PubMed ID: 34461754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of K2P channels in sensory and motor neurons of the autonomic nervous system.
    Cadaveira-Mosquera A; Pérez M; Reboreda A; Rivas-Ramírez P; Fernández-Fernández D; Lamas JA
    J Mol Neurosci; 2012 Sep; 48(1):86-96. PubMed ID: 22544515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The inhibitory effects of bupivacaine, levobupivacaine, and ropivacaine on K2P (two-pore domain potassium) channel TREK-1.
    Shin HW; Soh JS; Kim HZ; Hong J; Woo DH; Heo JY; Hwang EM; Park JY; Lee CJ
    J Anesth; 2014 Feb; 28(1):81-6. PubMed ID: 23797625
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Towards a TREK-1/2 (TWIK-Related K+ Channel 1 and 2) dual activator tool compound: Multi-dimensional optimization of BL-1249.
    Iwaki Y; Yashiro K; Kokubo M; Mori T; Wieting JM; McGowan KM; Bridges TM; Engers DW; Denton JS; Kurata H; Lindsley CW
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1601-1604. PubMed ID: 31072652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymodal Mechanism for TWIK-Related K+ Channel Inhibition by Local Anesthetic.
    Pavel MA; Chung HW; Petersen EN; Hansen SB
    Anesth Analg; 2019 Oct; 129(4):973-982. PubMed ID: 31124840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.